Pivotal Therapeutics PVTTF Stock
Pivotal Therapeutics Price Chart
Pivotal Therapeutics PVTTF Financial and Trading Overview
| Pivotal Therapeutics stock price | 0.0018 USD |
| Previous Close | 0.0018 USD |
| Open | 0.0018 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0018 - 0.0018 USD |
| 52 Week Range | 0.0001 - 0.0021 USD |
| Volume | 27.1K USD |
| Avg. Volume | 0 USD |
| Market Cap | 172.43K USD |
| Beta (5Y Monthly) | -976.1616 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.09 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PVTTF Valuation Measures
| Enterprise Value | 7.18M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.4830025 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 20.103 |
| Enterprise Value/EBITDA | -2.316 |
Trading Information
Pivotal Therapeutics Stock Price History
| Beta (5Y Monthly) | -976.1616 |
| 52-Week Change | 2000.00% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.0021 USD |
| 52 Week Low | 0.0001 USD |
| 50-Day Moving Average | 0.0021 USD |
| 200-Day Moving Average | 0.00196 USD |
PVTTF Share Statistics
| Avg. Volume (3 month) | 0 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 95.79M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0.45% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2014 |
| Most Recent Quarter (mrq) | September 30, 2015 |
| Next Fiscal Year End | December 31, 2015 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -905.21% |
| Gross Margin | -7.89% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -85.90% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 356.99K USD |
| Revenue Per Share (ttm) | 0.004 USD |
| Quarterly Revenue Growth (yoy) | 45.60% |
| Gross Profit (ttm) | -94863 USD |
| EBITDA | -3099341 USD |
| Net Income Avi to Common (ttm) | -3669641 USD |
| Diluted EPS (ttm) | -0.07 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 24.42K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 7.03M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.035 |
| Book Value Per Share (mrq) | -0.08 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1091613 USD |
| Levered Free Cash Flow (ttm) | 690.79K USD |
Profile of Pivotal Therapeutics
| Country | United States |
| State | ON |
| City | Woodbridge |
| Address | 81 Zenway Boulevard |
| ZIP | L4H 0S5 |
| Phone | 905-856-9797 |
| Website | https://www.pivotaltherapeutics.us |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Pivotal Therapeutics Inc., a specialty pharmaceutical company, focuses on the treatment of cardiovascular diseases and overall health. Its lead product, VASCAZEN, is a prescription only medical food formulated for clinical dietary management of cardiovascular disease in patients with documented coronary heart disease and who are deficient in blood Omega-3 fatty acids, eicosapentaenoic acid, and docosahexanenoic acid levels. The company also offers OMAZEN for the maintenance of good health through elevating Omega-3 fatty acid levels. In addition, the company develops Benefishial product line for overall health, cardiovascular health, prenatal health, toddler's health, child's health, and pet's health. Further, it is developing PVT-100 indicated for the stabilization of vulnerable plaque in patients undergoing carotid endarterectomy. Pivotal Therapeutics Inc. sells VASCAZEN in the United States and OMAZEN in Canada. The company is headquartered in Woodbridge, Canada.
Q&A For Pivotal Therapeutics Stock
What is a current PVTTF stock price?
Pivotal Therapeutics PVTTF stock price today per share is 0.0018 USD.
How to purchase Pivotal Therapeutics stock?
You can buy PVTTF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pivotal Therapeutics?
The stock symbol or ticker of Pivotal Therapeutics is PVTTF.
Which industry does the Pivotal Therapeutics company belong to?
The Pivotal Therapeutics industry is Drug Manufacturers-Specialty & Generic.
How many shares does Pivotal Therapeutics have in circulation?
The max supply of Pivotal Therapeutics shares is 95.79M.
What is Pivotal Therapeutics Price to Earnings Ratio (PE Ratio)?
Pivotal Therapeutics PE Ratio is now.
What was Pivotal Therapeutics earnings per share over the trailing 12 months (TTM)?
Pivotal Therapeutics EPS is -0.09 USD over the trailing 12 months.
Which sector does the Pivotal Therapeutics company belong to?
The Pivotal Therapeutics sector is Healthcare.